Bliss GVS Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
486.30
3.35 (0.69%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 10.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "486.30",
    "chg": 3.35,
    "chgp": "0.69%",
    "dir": 1,
    "prev_price": "482.95",
    "mcapval": "5,191.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Jun 19, 03:30 PM",
    "curr_time": "08:50 AM",
    "last_traded_at": "Jun 19, 03:30 PM IST",
    "bse_nse_vol": "10.22 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 19, 2026",
    "traded_date_str": "2026 06 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bliss-gvs-pharma-730684-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Bliss GVS Pharma Gains 11.07%: 6 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-1107-6-key-factors-driving-the-surge-4065606",
        "imagepath": "",
        "date": "2026-06-20 16:01:03",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> Stock opens at Rs.439.70, modest gain amid strong Sensex rally</p>\n                    <p><strong>17 Jun:</strong> New 52-week and all-time high at Rs.472.65 and Rs.472</p>\n                    <p><strong>18 Jun:</strong> Further 52-week and all-time high at Rs.483</p>\n                    <p><strong>19 Jun:</strong> New 52-week high at Rs.493.7 and all-time high at Rs.488.95</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.486.60, up 11.07% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.439.70</div></div..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 493.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs4937-4063358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4063358.png",
        "date": "2026-06-19 10:39:29",
        "description": "After a sustained rally of over 15% in just nine trading sessions, Bliss GVS Pharma Ltd surged to a fresh 52-week high of Rs 493.7 on 19 Jun 2026, marking a remarkable ascent from its 52-week low of Rs 118.35. This milestone underscores the stock’s strong price momentum and technical alignment amid a broader market environment that remains subdued."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits All-Time High of Rs 488.95 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-all-time-high-at-rs48895-on-19-june-2026-4062944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4062944.png",
        "date": "2026-06-19 09:46:30",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 483",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs483-4060772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4060772.png",
        "date": "2026-06-18 09:49:50",
        "description": "From a 52-week low of Rs 118.35 to a fresh peak of Rs 483 on 18 Jun 2026, Bliss GVS Pharma Ltd has surged an impressive 239.78% over the past year, vastly outperforming the Sensex’s decline of 5.14%. This remarkable rally is underpinned by a strong alignment of technical indicators and sustained price momentum, marking a significant milestone for the micro-cap pharmaceutical player."
      },
      {
        "title": "From Steady Gains to Record Close: Bliss GVS Pharma Ltd Hits All-Time High at Rs 483",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs483-4060710",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4060710.png",
        "date": "2026-06-18 09:31:39",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 472.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs47265-4058566",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4058566.png",
        "date": "2026-06-17 09:53:00",
        "description": "Surging past its previous peaks, Bliss GVS Pharma Ltd reached a new 52-week high of Rs 472.65 on 17 Jun 2026, marking a remarkable rally that has seen the stock appreciate by over 233% in the past year, vastly outperforming the Sensex’s decline of 5.54% over the same period."
      },
      {
        "title": "Bliss GVS Pharma Ltd Hits All-Time High of Rs 472 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs472-4058510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_priceRelatedfactors_4058510.png",
        "date": "2026-06-17 09:35:03",
        "description": ""
      },
      {
        "title": "Bliss GVS Pharma Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bliss-gvs-pharma-ltd-is-rated-hold-4052881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BlissGVSPharmaL_mojoScore_4052881.png",
        "date": "2026-06-14 10:10:04",
        "description": "Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Bliss GVS Pharma Gains 3.12%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-gains-312-5-key-factors-driving-the-weeks-momentum-4052281",
        "imagepath": "",
        "date": "2026-06-13 17:14:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock opens sharply lower at Rs.402.00 (-5.37%) amid broad market weakness</p>\n                    <p><strong>2 June:</strong> New 52-week high of Rs.440.15 and all-time high of Rs.429.35; hits upper circuit with 8.82% gain</p>\n                    <p><strong>3 June:</strong> Further new 52-week and all-time high at Rs.447.35 despite Sensex decline</p>\n                    <p><strong>4 June:</strong> Continued gains to Rs.456.85 (+3.97%) on moderate volume</p>\n                    <p><strong>5 June:</strong> Profit-taking leads to 4.12% decline, closing at Rs.438.05</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"st..."
      }
    ],
    "total": 379,
    "sid": "730684",
    "stock_news_url": "https://www.marketsmojo.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Updates",
      "datetime": "05-Nov-2019"
    },
    {
      "details": "Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled \"we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.\".",
      "source": "NSE",
      "caption": "Bliss GVS Pharma Limited - Press Release",
      "datetime": "09-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Bliss GVS Pharma Gains 11.07%: 6 Key Factors Driving the Surge

2026-06-20 16:01:03

Key Events This Week

15 Jun: Stock opens at Rs.439.70, modest gain amid strong Sensex rally

17 Jun: New 52-week and all-time high at Rs.472.65 and Rs.472

18 Jun: Further 52-week and all-time high at Rs.483

19 Jun: New 52-week high at Rs.493.7 and all-time high at Rs.488.95

19 Jun: Week closes at Rs.486.60, up 11.07% for the week

stock-recommendationAnnouncement

Bliss GVS Pharma Limited - Updates

13-Nov-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding 'Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the second quarter and half year ended September 30, 2019 published in The Economic Times & The Free Press Journal an English Daily and Maharashtra Times & Navshkati a Regional Daily, on November 13, 2019.

Bliss GVS Pharma Limited - Updates

05-Nov-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding 'Please find enclosed herewith the copy of the newspaper advertisement of notice of Board Meeting of the Company will be held on Monday, November 11, 2019 at the registered office of the Company, inter-alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2019 published in The Economic Times an English Daily and Maharashtra Times a Regional Daily, on November 05, 2019.

Bliss GVS Pharma Limited - Press Release

09-Oct-2019 | Source : NSE

Bliss GVS Pharma Limited has informed the Exchange regarding a press release dated October 07, 2019, titled "we enclose herewith Press Release announcing that Kremoint Pharma Private Limited, India, a 70% subsidiary of Bliss GVS Pharma Limited (BGPL) has received a compliant certification from the U.S. Food and Drug Administration (FDA) that was based on the inspection conducted at the Company s facility located at M.I.D.C, Ambernath (East), Thane-District.".

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bliss GVS Pharma Ltd has declared 50% dividend, ex-date: 18 Feb 26

stock-summary
SPLITS

Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08

stock-summary
BONUS

Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08

stock-summary
RIGHTS

No Rights history available